ClinVar Miner

Submissions for variant NM_020975.6(RET):c.1039G>A (p.Val347Met)

dbSNP: rs1467660660
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001017116 SCV001178146 uncertain significance Hereditary cancer-predisposing syndrome 2023-02-06 criteria provided, single submitter clinical testing The p.V347M variant (also known as c.1039G>A), located in coding exon 5 of the RET gene, results from a G to A substitution at nucleotide position 1039. The valine at codon 347 is replaced by methionine, an amino acid with highly similar properties. This alteration was identified in 1 individual in a cohort of patients with short-segment Hirschsprung disease and 0 controls. (Tang CS et al. Gastroenterology, 2018 Dec;155:1908-1922.e5). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Labcorp Genetics (formerly Invitae), Labcorp RCV001860854 SCV002300900 uncertain significance Multiple endocrine neoplasia, type 2 2024-10-22 criteria provided, single submitter clinical testing This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 347 of the RET protein (p.Val347Met). This variant is present in population databases (no rsID available, gnomAD 0.006%). This missense change has been observed in individual(s) with Hirschsprung disease (PMID: 30217742). ClinVar contains an entry for this variant (Variation ID: 822070). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Baylor Genetics RCV003461357 SCV004206722 uncertain significance Hirschsprung disease, susceptibility to, 1 2023-06-06 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV004998548 SCV005623053 uncertain significance not provided 2024-01-02 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.